In the risk classification for thrombosis described by Barbui et al. [3], which is also in the guidelines and further incorporates the presence or absence of JAK2 mutations, Cases 2, 3 and 4 are classified as high risk (Table 2). The gene discussed is JAK2; the disease is deep vein thrombosis.